Literature DB >> 8631275

PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.

M F Offield1, T L Jetton, P A Labosky, M Ray, R W Stein, M A Magnuson, B L Hogan, C V Wright.   

Abstract

It has been proposed that the Xenopus homeobox gene, XlHbox8, is involved in endodermal differentiation during pancreatic and duodenal development (Wright, C.V.E., Schnegelsberg, P. and De Robertis, E.M. (1988). Development 105, 787-794). To test this hypothesis directly, gene targeting was used to make two different null mutations in the mouse XlHbox8 homolog, pdx-1. In the first, the second pdx-1 exon, including the homeobox, was replaced by a neomycin resistance cassette. In the second, a lacZ reporter was fused in-frame with the N terminus of PDX-1, replacing most of the homeodomain. Neonatal pdx-1 -/- mice are apancreatic, in confirmation of previous reports (Jonsson, J., Carlsson, L., Edlund, T. and Edlund, H. (1994). Nature 371, 606-609). However, the pancreatic buds do form in homozygous mutants, and the dorsal bud undergoes limited proliferation and outgrowth to form a small, irregularly branched, ductular tree. This outgrowth does not contain insulin or amylase-positive cells, but glucagon-expressing cells are found. The rostral duodenum shows a local absence of the normal columnar epithelial lining, villi, and Brunner's glands, which are replaced by a GLUT2-positive cuboidal epithelium resembling the bile duct lining. Just distal of the abnormal epithelium, the numbers of enteroendocrine cells in the villi are greatly reduced. The PDX-1/beta-galactosidase fusion allele is expressed in pancreatic and duodenal cells in the absence of functional PDX-1, with expression continuing into perinatal stages with similar boundaries and expression levels. These results offer additional insight into the role of pdx-1 in the determination and differentiation of the posterior foregut, particularly regarding the proliferation and differentiation of the pancreatic progenitors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631275     DOI: 10.1242/dev.122.3.983

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  511 in total

1.  Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription.

Authors:  M K Thomas; K M Yao; M S Tenser; G G Wong; J F Habener
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter.

Authors:  K Ohneda; R G Mirmira; J Wang; J D Johnson; M S German
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

3.  Pdx1 restores beta cell function in Irs2 knockout mice.

Authors:  Jake A Kushner; Jing Ye; Markus Schubert; Deborah J Burks; Matthew A Dow; Carrie L Flint; Sanjoy Dutta; Christopher V E Wright; Marc R Montminy; Morris F White
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

4.  Acinar-to-ductal metaplasia in pancreatic cancer development.

Authors:  Roland M Schmid
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 5.  Developmental aspects of the endocrine pancreas.

Authors:  Daniel M Kemp; Melissa K Thomas; Joel F Habener
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 6.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

7.  ATF2 interacts with beta-cell-enriched transcription factors, MafA, Pdx1, and beta2, and activates insulin gene transcription.

Authors:  Song-iee Han; Kunio Yasuda; Kohsuke Kataoka
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

8.  Fine-tuning and autoregulation of the intestinal determinant and tumor suppressor homeobox gene CDX2 by alternative splicing.

Authors:  Camille Balbinot; Marie Vanier; Olivier Armant; Asmaa Nair; Julien Penichon; Christine Soret; Elisabeth Martin; Thoueiba Saandi; Jean-Marie Reimund; Jacqueline Deschamps; Felix Beck; Claire Domon-Dell; Isabelle Gross; Isabelle Duluc; Jean-Noël Freund
Journal:  Cell Death Differ       Date:  2017-09-01       Impact factor: 15.828

Review 9.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

10.  The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Authors:  Brian C Lewis; David S Klimstra; Harold E Varmus
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.